Learn

The prevalence of neuromuscular disorders in Australia and New Zealand is estimated to lie between 23 and 160 per 100 000 population. Progressive weakening of the respiratory muscles responsible for inspiration, coughing, and maintaining upper airway clearance can lead to chronic respiratory failure, reducing quality of life and accounting for 80% of the morbidity and mortality associated with some neuromuscular disorders.

Home‐based, non‐invasive ventilation is important for many people with neuromuscular disorders and chronic respiratory failure. Night‐time use is initially typical, but dependency may increase (more than fifteen hours a day). Use of home‐based non‐invasive ventilation for people with neuromuscular disorders has increased over the last seven years in New Zealand, to 4.8 per 100 000 population in 2022.

This MJA research shared more.

Learning Outcomes

1. Explain key components of the research
2. List main findings
3. Describe the importance of equitable and high quality non-invasive ventilation respiratory care.

Details

Author: Meredith A Perry, Bernadette Jones, Hemakumar Devan, Alister Neill, Amanda Piper and Tristram Ingham

Article Type: Research